Assessment of various formulation approaches for the application of beta-lapachone in prostate cancer therapy.

MLA

Wu, Xiao, et al. “Assessment of Various Formulation Approaches for the Application of Beta-Lapachone in Prostate Cancer Therapy.” International Journal of Pharmaceutics, vol. 579, Apr. 2020, p. 119168. EBSCOhost, https://doi.org/10.1016/j.ijpharm.2020.119168.

APA

Wu, X., Kasselouri, A., Vergnaud-Gauduchon, J., & Rosilio, V. (2020). Assessment of various formulation approaches for the application of beta-lapachone in prostate cancer therapy. International Journal of Pharmaceutics, 579, 119168. https://doi.org/10.1016/j.ijpharm.2020.119168

Chicago

Wu, Xiao, Athena Kasselouri, Juliette Vergnaud-Gauduchon, and Véronique Rosilio. 2020. “Assessment of Various Formulation Approaches for the Application of Beta-Lapachone in Prostate Cancer Therapy.” International Journal of Pharmaceutics 579 (April): 119168. doi:10.1016/j.ijpharm.2020.119168.